Monocentric, prospective, randomized placebo-controlled double-blind phase II trial exploring protective effects of Ginkgo biloba special extract EGb 761® against noise-induced temporary hearing impairment

Trial Profile

Monocentric, prospective, randomized placebo-controlled double-blind phase II trial exploring protective effects of Ginkgo biloba special extract EGb 761® against noise-induced temporary hearing impairment

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Noise-induced hearing loss
  • Focus Therapeutic Use
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals
  • Most Recent Events

    • 10 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 15 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top